gvtcx

Provision of medicines supply chain information: supporting ICU medicines supply during COVID-19 response. Phase Two

NHS Improvements Published 30 Sept 2020 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£90,000
Statuscomplete
Category (CPV) 73000000
Deadline30 May 2020
Contract start1 Jun 2020
Contract end31 Jul 2020
Procedureselective
SME suitableNo
OCIDocds-b5fd17-659f4ae8-94d7-4ea8-904e-9d1764b0cba6

Award

SupplierValueDateStatus
ERNST & YOUNG LLP £90,000 27 May 2020 active

description

NHS England & Improvement (NHSE&I) require visibility of the medicines supply chain and national stockholding of priority ICU medicines. Such information supports NHSE&I to allocate and distribute medicines equitably, based on need, to NHS Trusts in England and across the devolved administrations. An understanding of national stock holdings allows us to plan for shortages, manage shortages and engage with industry on areas for priority manufacture. Several medicines are in extremely high demand and the profile of use has changed: COVID-19 treatment requires far higher volumes of certain medicines per patient compared to BAU treatment - primarily due to the length of sedation needed.

Additional information: n/a

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
30 Sept 2020 Award (award) · e3758938-5f82-4fa4-959c-ebcd135271a1-384336

more from NHS Improvements

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.